Vodafone Idea board will consider raising funds via equity shares and warrants as sentiment improves after AGR relief and regulatory clarity. The stock has rallied sharply in recent months on reduced dues, leadership changes and stake-related developments. Brokerages turn more positive, citing improved visibility for fundraising and network expansion plans.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore
May 12, 2026